{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T18:45:48Z","timestamp":1720550748072},"reference-count":29,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2191,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1111\/j.1524-4741.2009.00825.x","type":"journal-article","created":{"date-parts":[[2009,9,22]],"date-time":"2009-09-22T14:35:20Z","timestamp":1253630120000},"page":"S33-S38","source":"Crossref","is-referenced-by-count":7,"special_numbering":"supplement","title":["Establishing a Family Risk Assessment Clinic for Breast Cancer"],"prefix":"10.1155","volume":"15","author":[{"given":"Jurgen","family":"Mulsow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathriona","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James G.","family":"Geraghty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB1","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.ejca.2007.12.015","article-title":"Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s","volume":"44","author":"Karim-Kos","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB2","unstructured":"2.All Ireland Cancer Statistics Report 1998-2000. Available at: http:\/\/www.ncri.ie\/pubs\/pubfiles\/allireland1998-2000.pdf (last accessed April 2009)."},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB3","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/jnci\/92.14.1126","article-title":"Genetic and hormonal risk factors in breast cancer","volume":"92","author":"Martin","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB4","unstructured":"4.NICE Guidelines. Familial Breast Cancer. The Classification and Care of Women at Risk of Familial Breast Cancer in Primary, Secondary, and Tertiary Care. Available at:. http:\/\/guidance.nice.org.uk\/cg41\/niceguidance\/pdf\/English."},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1136\/jmg.2003.017996","article-title":"A new scoring system for the chances of identifying a BRCA1\/2 mutation outperforms existing models including BRCAPRO","volume":"41","author":"Evans","year":"2004","journal-title":"J Med Genet"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB6","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1136\/jmg.2005.031989","article-title":"Update on the Manchester scoring system for BRCA1 and BRCA2 testing","volume":"42","author":"Evans","year":"2005","journal-title":"J Med Genet"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB8","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1200\/JCO.2005.01.9737","article-title":"Optimal selection of individuals for BRCA mutation testing: a comparison of available methods","volume":"24","author":"James","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1200\/JCO.2003.07.007","article-title":"Application of breast cancer risk prediction models in clinical practice","volume":"21","author":"Domchek","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1001\/jama.292.12.1480","article-title":"Does this patient have a family history of cancer? An evidence-based analysis of the accuracy of family cancer history","volume":"292","author":"Murff","year":"2004","journal-title":"JAMA"},{"issue":"Suppl. 8","key":"10.1111\/j.1524-4741.2009.00825.x-BIB12","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0959-8049(01)00255-6","article-title":"Genetics and the common cancers","volume":"37","author":"Peto","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/jmg.2004.022731","article-title":"Clinical genetic counselling for familial cancers requires reliable data on familial cancer risks and general action plans","volume":"41","author":"Hemminki","year":"2004","journal-title":"J Med Genet"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB14","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0748-7983(98)80005-X","article-title":"False family history of breast cancer in the family cancer clinic","volume":"24","author":"Kerr","year":"1998","journal-title":"Eur J Surg Oncol"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB15","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ejca.2006.01.055","article-title":"Screening younger women with a family history of breast cancer - does early detection improve outcome?","volume":"42","author":"Maurice","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB16","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.ejhg.5201895","article-title":"Risk estimation for familial breast cancer: improving the system of counselling","volume":"15","author":"Gregory","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10689-006-0006-8","article-title":"Screening behavior in women at increased familial risk for breast cancer","volume":"5","author":"Antill","year":"2006","journal-title":"Fam Cancer"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1524-4741.2009.00690.x","article-title":"Identification and management of women at high risk for hereditary breast\/ovarian cancer syndrome","volume":"15","author":"Ozanne","year":"2009","journal-title":"Breast J."},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB19","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB20","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","article-title":"Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers","volume":"93","author":"Hartmann","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa020119","article-title":"Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation","volume":"346","author":"Kauff","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB22","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1056\/NEJMoa012158","article-title":"Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations","volume":"346","author":"Rebbeck","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ejca.2005.11.020","article-title":"Risk-reducing surgery in women with familial susceptibility for breast and\/or ovarian cancer","volume":"42","author":"Antill","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB24","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jama.284.3.319","article-title":"Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy","volume":"284","author":"Frost","year":"2000","journal-title":"JAMA"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB25","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1200\/JCO.2003.09.052","article-title":"Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation","volume":"21","author":"Meijers-Heijboer","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB26","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB27","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1200\/JCO.2002.06.029","article-title":"American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase inhibition","volume":"20","author":"Chlebowski","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/jnci\/djk154","article-title":"Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy","volume":"99","author":"Veronesi","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1524-4741.2009.00825.x-BIB29","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1016\/S0140-6736(00)03258-X","article-title":"Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group","volume":"356","author":"Narod","year":"2000","journal-title":"Lancet"}],"container-title":["The Breast Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1524-4741.2009.00825.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1524-4741.2009.00825.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:25:58Z","timestamp":1643351158000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1524-4741.2009.00825.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1111\/j.1524-4741.2009.00825.x","relation":{},"ISSN":["1075-122X","1524-4741"],"issn-type":[{"value":"1075-122X","type":"print"},{"value":"1524-4741","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}